Showing results (41-50 of 53) with videos related to

Sort By:
Pageof 6
Cancers|April 15, 2020
Tumor Biomarkers for the Prediction of Distant Metastasis in Head and Neck Squamous Cell CarcinomaSalvatore Alfieri, Andrea Carenzo, Francesca Platini, et al.
Targeted Oncology|November 10, 2021
Retrospective Chart Review of Dabrafenib Plus Trametinib in Patients with Metastatic BRAF V600-Mutant Melanoma Treated in the Individual Patient Program (DESCRIBE Italy)Massimo Aglietta, Vanna Chiarion-Sileni, Paolo Fava, et al.
Tumori|July 7, 2023
Outcomes in patients with BRAFV600-mutated melanoma and brain metastases at baseline treated with dabrafenib plus trametinibMassimo Aglietta, Vanna Chiarion-Sileni, Paolo Fava, et al.
World Neurosurgery|January 17, 2018
The Prognostic Roles of Gender and O6-Methylguanine-DNA Methyltransferase Methylation Status in Glioblastoma Patients: The Female PowerEnrico Franceschi, Alicia Tosoni, Santino Minichillo, et al.
NPJ Precision Oncology|February 1, 2024
Autologous anti-GD2 CAR T cells efficiently target primary human glioblastomaChiara Chiavelli, Malvina Prapa, Giulia Rovesti, et al.
European Journal of Cancer (Oxford, England : 1990)|August 7, 2023
Italian nivolumab Expanded Access Programme in melanoma adjuvant setting: patient outcomes and safety profilePaolo A Ascierto, Anna M Di Giacomo, Vanna Chiarion Sileni, et al.
European Journal of Cancer (Oxford, England : 1990)|September 18, 2021
Real world data of cemiplimab in locally advanced and metastatic cutaneous squamous cell carcinomaAlice Baggi, Pietro Quaglino, Marco Rubatto, et al.
European Journal of Cancer (Oxford, England : 1990)|January 24, 2024
Combined immunotherapy in melanoma patients with brain metastases: A multicenter international studyMario Mandalà, Paul Lorigan, Maria Chiara Sergi, et al.
European Journal of Cancer (Oxford, England : 1990)|June 12, 2025
Combined immunotherapy with nivolumab and ipilimumab with and without sequential or concomitant stereotactic radiotherapy in patients with melanoma brain metastasis: An international retrospective studyMario Mandalà, Teresa Amaral, Piotr Rutkowski, et al.
Pigment Cell & Melanoma Research|April 20, 2026
Dissecting the Spectrum of Rare BRAF Mutations in Melanoma: A Nation-Wide Study by the Italian Melanoma Intergroup (IMI)Bruna Dalmasso, Maria Chiara Scaini, Laura Cendron, et al.
Pageof 6